Potentiating effects of drugs on the binding of glibenclamide to pancreatic beta cells.
D000818:Animals; D001665:Binding Sites; D004357:Drug Synergism; D005260:Female; D005905:Glyburide / Q000378:metabolism*; D006943:Hyperglycemia / Q000378:metabolism; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism*; D051379:Mice; D010653:Phenylbutazone / Q000494:pharmacology*; D012709:Serum Albumin / Q000378:metabolism; D013395:Sucrose / Q000378:metabolism; D013426:Sulfaphenazole / Q000494:pharmacology; D013443:Sulfisomidine / Q000494:pharmacology; D013444:Sulfisoxazole / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology*; D014044:Tolbutamide / Q000494:pharmacology
D007328:Insulin; D012709:Serum Albumin; D013449:Sulfonamides; D013426:Sulfaphenazole; D013395:Sucrose; D013444:Sulfisoxazole; D014044:Tolbutamide; D010653:Phenylbutazone; D005905:Glyburide; D013443:Sulfisomidine